Results from a stimulated clinical trial which discovered a genetic test for breast cancer that was cost effective when used to guide MRI screenings was announced by Archimedes. The study, "Cost-effectiveness of a genetic test for breast cancer risk," appeared in the December 5th online issue of the peer-reviewed journal iCancer Prevention Research/i. "This Archimedes Model simulation suggests that genetic screening for breast cancer risk in conjunction with ...
Read More
No comments:
Post a Comment